ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.74
-0.53%
US Tech 100
19,973.60
0.56%
S&P 500
5,870.62
-1.32%
US Dollar vs CAD
1.41004
0.10%
Bitcoin
91,944.72
2.31%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Bioventus Inc (BVS) Share Price

Bioventus Inc

Bioventus Inc (BVS)

Bravura Solutions Limited
11.24
0.11
(0.99%)
Closed November 15 3:00PM
Delayed by 15 minutes
11.24
0.00
( 0.00% )
Pre Market: 3:00AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
11.24
Bid
3.19
Ask
11.22
Volume
-
0.00 Day's Range 0.00
3.67 52 Week Range 14.38
Market Cap
912.177M
Previous Close
11.24
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
483,744
Shares Outstanding
81,154,567
Dividend Yield
-
PE Ratio
-5.84
Earnings Per Share (EPS)
-1.93
Revenue
512.35M
Net Profit
-156.23M

About Bioventus Inc

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, in... Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.bioventus.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Bioventus Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker BVS. The last closing price for Bioventus was US$11.24. Over the last year, Bioventus shares have traded in a share price range of US$ 3.67 to US$ 14.38.

Bioventus currently has 81,154,567 shares outstanding. The market capitalization of Bioventus is US$912.18 million. Bioventus has a price to earnings ratio (PE ratio) of -5.84.

Ask ADVFN Intelligence (AI)

BVS Latest News

More News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 05 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 05 2024
Edgar (US Regulatory)

Bioventus Reports Third Quarter Financial Results

Q3 Revenue Advanced by 15.0%, Fourth Straight Quarter of Double Digit Organic* GrowthQ3 Gross Margin Expanded 200 bpsQ3 Cash from Operations of $10.3 million, an Increase of $18.6 million Compared...

November 05 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

November 04 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

November 04 2024
Edgar (US Regulatory)

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024

DURHAM, N.C., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will...

October 29 2024
GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933

October 25 2024
Edgar (US Regulatory)

Form 8-K - Current report

October 04 2024
Edgar (US Regulatory)

Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

DURHAM, N.C., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has signed...

October 01 2024
GlobeNewswire Inc.

Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference

DURHAM, N.C., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and...

August 07 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.89-7.3371805441112.1312.6110.9638078911.62412737CS
4-1.72-13.271604938312.9614.387.348699312.16946798CS
121.2412.41014.387.348374411.50036526CS
265.0982.76422764236.1514.385.285173729.1470575CS
527.34188.2051282053.914.383.673600937.99188057CS
156-3.67-24.614352783414.9115.570.79994292575.17493483CS
260-3.86-25.562913907315.119.94090.79993845606.35100285CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
US$ 14.39
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 64.84
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.11
(0.00%)
0
AACGATA Creativity Global
US$ 1.01
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 14.39
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 64.84
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.11
(0.00%)
0
AACGATA Creativity Global
US$ 1.01
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 14.39
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 64.84
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.11
(0.00%)
0
AACGATA Creativity Global
US$ 1.01
(0.00%)
0

BVS Discussion

View Posts
Monksdream Monksdream 2 weeks ago
BVS 10Q 11/5
👍️0
Monksdream Monksdream 4 weeks ago
BVS anew 52 week high
👍️0
Monksdream Monksdream 3 months ago
BVS new 52=high
👍️0
Monksdream Monksdream 3 months ago
BVS new 52 week high
👍️0
Monksdream Monksdream 5 months ago
BVS under $10
👍️0
tw0122 tw0122 6 months ago
Durolane like it .. older news ..Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis

Source: GlobeNewswire Inc.

Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract with Aetna™ Medicare Advantage plans. Beginning January 1, 2024, over 3 million Aetna™ Medicare Advantage plan members will have access to DUROLANE to treat knee osteoarthritis (OA) pain. DUROLANE, is a single-injection hyaluronic acid (HA)-based joint-fluid treatment for patients. DUROLANE will be one of two single-injection HA products under contract.
OA involves the breakdown, or degeneration, of cartilage and the synovial fluid that cushions and lubricates joint tissues. Injection treatments of HA-based products, such as DUROLANE, help manage knee OA pain.

“We are pleased DUROLANE is among the preferred options available to both Aetna™ Medicare Advantage members and physicians,” said Anthony Doyle, General Manager, Pain Treatments and Restorative Therapies for Bioventus. “Both now have access to a safe HA product that is proven to provide relief from knee OA pain.”

About Bioventus

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

👍️0
TheFinalCD TheFinalCD 6 months ago
$BVS - Bioventus GAAP EPS of -$0.07 beats by $0.18, revenue of $129.45M beats by $11.07M https://t.co/IGk1Zy2r5X— Seeking Alpha Market News (@MarketCurrents) May 7, 2024
👍️0
Monksdream Monksdream 7 months ago
BVS under $5

👍️0

Your Recent History

NASDAQ
BVS
Bioventus
TSX
KNT
K92 Mining
USOTC
QNTO
Quaint Oak Bancorp (QB)
ASX
IDZN
LSE
57UT
Grand Union 43
NASDAQ
AMBA
Ambarella
USOTC
CVVTF
Covestro (PK)
NYSE
FUBO
fuboTV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved